Marrone Bio Innovations Appoints Kevin Hammill as New Chief Commercial Officer
May 07 2018 - 8:31AM
Marrone Bio Innovations, Inc. (NASDAQ:MBII) (MBI), a leading
provider of bio-based pest management and plant health products for
the agriculture, turf and ornamental and water treatment markets,
is pleased to announce that Kevin Hammill has joined as Chief
Commercial Officer.
Mr. Hammill brings over 25 years of
leadership experience and broad commercial success in the crop
protection (row crop, non-crop, horticulture, soil and seed), plant
nutrition and biotechnology industries.
Most recently, Mr. Hammill was Chief Operating
Officer at Pivot Bio, a startup company which harnesses the innate
ability of naturally occurring microbes to provide crops with
nutrients exactly when they need it the most. Prior to Pivot Bio,
Hammill was at Valent USA, a division of Sumitomo Chemical, where
he oversaw the U.S. Marketing Group, seed treatment business unit
and Canadian business operations. Over his 12 years at Valent,
Hammill created and directed new growth platforms, commercial
alliances, licensing agreements, strategic initiatives and
technology adoption that resulted in significant incremental
growth and margin to the company.
Before Valent, Mr. Hammill had multiple sales
and marketing management positions over the course of 12 years at
BASF and American Cyanamid (acquired by BASF in 2000), such as
Director of Marketing and Sales, Regional Sales Manager, and
Product Manager. He established and implemented strategic
direction for a multi-hundred million dollar product portfolio,
overseeing global brands and intellectual property, negotiating and
managing global licensing agreements with market-leading bioscience
and biotechnology companies, identifying high potential market
segments, and developing key strategic alliances. As the Director
of Sales and Marketing, Mr. Hammill managed the business unit
P&L and led a team of marketing, sales, and technical
development professionals. In the role of Regional Sales and
National Accounts Manager, he managed a high-caliber sales team and
was responsible for forging a productive relationship with
distribution customers to facilitate the attainment of mutual
business goals.
Mr. Hammill has a Bachelor of Science
degree in Agriculture and a Master’s degree in Agriculture Business
from the University of Guelph, Ontario, Canada.
“I joined MBI because I believe that their
highly-effective and widely respected biological products have
tremendous potential in the market. I look forward to
leveraging my more than two decades of commercial leadership
experience to drive forward MBI’s growth plans,” said Mr.
Hammill, Chief Commercial Officer of MBI.
“I am thrilled to have someone with Kevin’s
acumen and track record of proven results lead our commercial
business and collaborate with the rest of our leadership team to
grow our sales and enhance value to our shareholders, employees and
customers,” said Pam Marrone, CEO and Founder of MBI.
About Marrone Bio Innovations
Bio With Bite.
Marrone Bio Innovations, Inc. (NASDAQ:MBII)
strives to lead the movement to a more sustainable world through
the discovery, development and promotion of biological products for
pest management and plant health. MBI’s effective and
environmentally responsible pest management solutions help
customers operate more sustainably while uniquely improving plant
health and increasing crop yields. MBI’s currently available
commercial products are Regalia®, Grandevo®, Venerate®, Majestene®,
Haven® StargusTM and AmplitudeTM, ZeltoTM and Zequanox®. MBI also
distributes Bio-tam 2.0® for Isagro USA and Jet-Ag® for Jet Harvest
in most regions of the U.S.
Marrone Bio Innovations is dedicated to
pioneering smart biopesticide solutions that support a better
tomorrow for both farmers, turf managers and consumers around the
globe. For more information, please visit www.marronebio.com.
Marrone Bio Innovations Forward Looking
Statements
This press release contains forward-looking
statements that involve substantial risks and uncertainties.
All statements, other than statements of historical facts, included
in this press release regarding strategy, future operations and
plans, including assumptions underlying such statements, are
forward-looking statements, and should not be relied upon as
representing MBI’s views as of any subsequent date. Examples
of such statements include the potential of our new Chief
Commercial Officer to drive sales, provide market projections, and
realize the potential benefits of our products. Such
forward-looking statements are based on information available to
the Company as of the date of this release and involve a number of
risks and uncertainties, some beyond the Company's control, that
could cause actual results to differ materially from those
anticipated by these forward-looking statements, including weather,
regulatory and other factors affecting demand for the MBI’s
products, any difficulty in marketing MBI’s products in its target
markets, competition in the market for pest management products,
lack of understanding of bio-based pest management products by
customers and growers. Additional information that could lead
to material changes in MBI’s performance is contained in its
filings with the SEC. MBI is under no obligation to, and
expressly disclaims any responsibility to, update or alter
forward-looking statements contained in this release, whether as a
result of current information, future events or otherwise.
Marrone Bio Innovations Contacts: Pam Marrone,
CEO and Founder Telephone: +1 (530) 750-2800 Email:
Info@marronebio.com
MBI Investor Relations: Greg Falesnik Managing
Director MZ Group – MZ North America Main: 949-385-6449
MBII@mzgroup.us www.mzgroup.us
Marrone Bio Innovations (NASDAQ:MBII)
Historical Stock Chart
From Aug 2024 to Sep 2024
Marrone Bio Innovations (NASDAQ:MBII)
Historical Stock Chart
From Sep 2023 to Sep 2024